Delivery Order SPE2DB22D3301-SPE2DB24FY0YN
Award Date
2/16/24
Potential Completion Date
2/20/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,866.06 firm-fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,652.50 delivery order contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 50ML, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of June 14, 2024. This award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The award, valued at $3,498.20, is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a specialty pharmaceutical product, to DLA Troop Support Medical facilities that support the Department of Defense. The contract is a firm fixed price delivery order with a completion date of March 19, 2024. It is not associated with a larger...
This federal contract award, valued at $2,279.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product, with a period of performance through February 16, 2024. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has a completion date of June 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $1,200.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product, with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,690.80 and a period of performance through May 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, with a value of $1,726.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has a period of performance through June 25, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating the contract was competed openly....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the U.S. Department of Defense (DoD) Medical Supply Chain for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The $6,867.92 delivery order contract is a firm fixed-price arrangement without any set-aside designation. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to...
This federal contract award is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML medical supplies, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,690.80 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the vendor holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...